279 related articles for article (PubMed ID: 37086098)
1. Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium-glucose cotransporter 2 inhibitors.
Packer M
Eur Heart J; 2023 Dec; 44(48):5027-5035. PubMed ID: 37086098
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
Packer M
Am J Kidney Dis; 2021 Feb; 77(2):280-286. PubMed ID: 32711072
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal Anemia.
Packer M
Am J Nephrol; 2024; 55(2):255-259. PubMed ID: 37231827
[TBL] [Abstract][Full Text] [Related]
4. Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stress.
Packer M
Cardiovasc Res; 2021 Jan; 117(1):74-84. PubMed ID: 32243505
[TBL] [Abstract][Full Text] [Related]
5. Competing Effects of Renin Angiotensin System Blockade and Sodium-Glucose Cotransporter-2 Inhibitors on Erythropoietin Secretion in Diabetes.
Marathias KP; Lambadiari VA; Markakis KP; Vlahakos VD; Bacharaki D; Raptis AE; Dimitriadis GD; Vlahakos DV
Am J Nephrol; 2020; 51(5):349-356. PubMed ID: 32241009
[TBL] [Abstract][Full Text] [Related]
6. Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart Failure.
Packer M
JACC Heart Fail; 2023 Jan; 11(1):106-114. PubMed ID: 36396554
[TBL] [Abstract][Full Text] [Related]
7. Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.
Packer M
J Am Soc Nephrol; 2020 May; 31(5):907-919. PubMed ID: 32276962
[TBL] [Abstract][Full Text] [Related]
8. Novel perspectives regarding the physiologic mechanisms by which gliflozins induce reticulocytosis and erythrocytosis.
Heyman SN; Armaly Z; Hamo-Giladi DB; Abassi Z
Am J Physiol Endocrinol Metab; 2023 Nov; 325(5):E621-E623. PubMed ID: 37819195
[TBL] [Abstract][Full Text] [Related]
9. Role of Deranged Energy Deprivation Signaling in the Pathogenesis of Cardiac and Renal Disease in States of Perceived Nutrient Overabundance.
Packer M
Circulation; 2020 Jun; 141(25):2095-2105. PubMed ID: 32164457
[TBL] [Abstract][Full Text] [Related]
10. S1P Stimulates Erythropoietin Production in Mouse Renal Interstitial Fibroblasts by S1P
Hafizi R; Imeri F; Wenger RH; Huwiler A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502385
[TBL] [Abstract][Full Text] [Related]
11. Role of ketogenic starvation sensors in mediating the renal protective effects of SGLT2 inhibitors in type 2 diabetes.
Packer M
J Diabetes Complications; 2020 Sep; 34(9):107647. PubMed ID: 32534886
[TBL] [Abstract][Full Text] [Related]
12. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.
Kapitsinou PP; Liu Q; Unger TL; Rha J; Davidoff O; Keith B; Epstein JA; Moores SL; Erickson-Miller CL; Haase VH
Blood; 2010 Oct; 116(16):3039-48. PubMed ID: 20628150
[TBL] [Abstract][Full Text] [Related]
13. Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells.
Hafizi R; Imeri F; Stepanovska Tanturovska B; Manaila R; Schwalm S; Trautmann S; Wenger RH; Pfeilschifter J; Huwiler A
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682566
[TBL] [Abstract][Full Text] [Related]
14. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB
J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
[TBL] [Abstract][Full Text] [Related]
15. Interplay of adenosine monophosphate-activated protein kinase/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: A novel conceptual framework.
Packer M
Diabetes Obes Metab; 2020 May; 22(5):734-742. PubMed ID: 31916329
[TBL] [Abstract][Full Text] [Related]
16. High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection.
Umino H; Hasegawa K; Minakuchi H; Muraoka H; Kawaguchi T; Kanda T; Tokuyama H; Wakino S; Itoh H
Sci Rep; 2018 May; 8(1):6791. PubMed ID: 29717156
[TBL] [Abstract][Full Text] [Related]
17. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1.
Dioum EM; Chen R; Alexander MS; Zhang Q; Hogg RT; Gerard RD; Garcia JA
Science; 2009 Jun; 324(5932):1289-93. PubMed ID: 19498162
[TBL] [Abstract][Full Text] [Related]
18. Mutual Antagonism of Hypoxia-Inducible Factor Isoforms in Cardiac, Vascular, and Renal Disorders.
Packer M
JACC Basic Transl Sci; 2020 Sep; 5(9):961-968. PubMed ID: 33015417
[TBL] [Abstract][Full Text] [Related]
19. How can sodium-glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron-deficient? Implications for understanding iron homeostasis in heart failure.
Packer M
Eur J Heart Fail; 2022 Dec; 24(12):2287-2296. PubMed ID: 36377108
[TBL] [Abstract][Full Text] [Related]
20. Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium-glucose cotransporter 2 inhibitors.
Packer M
Eur J Heart Fail; 2020 Apr; 22(4):618-628. PubMed ID: 32037659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
